Eaton Vance Management Novo Nordisk A S Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Eaton Vance Management holds 1,088,926 shares of NVO stock, worth $95.1 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

1,088,926

Previous 279,848 289.11%

Holding current value

$95.1 Million

Previous $31.2 Million 247.9%

% of portfolio

0.16%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $77.1 Million - $94.6 Million	809,078 Added 289.11%	1,088,926 $108 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $909,750 - $1.07 Million	-8,812 Reduced 3.05%	279,848 $31.2 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $1.58 Million - $1.92 Million	17,018 Added 6.26%	288,660 $32.1 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $178,336 - $217,768	-1,860 Reduced 0.68%	271,642 $29.2 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $684,815 - $864,901	8,112 Added 3.06%	273,502 $25.2 Million
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $56,496 - $70,774	-835 Reduced 0.31%	265,390 $22.2 Million
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $13.3 Million - $15 Million	-197,760 Reduced 42.62%	266,225 $17.9 Million
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $44.9 Million - $51.8 Million	-702,329 Reduced 60.22%	463,985 $32.4 Million
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $12.2 Million - $13.4 Million	-191,280 Reduced 14.09%	1,166,314 $81 Million
Q2 2020 Nov 20, 2020	SELL	$58.54 - $67.94 $37,524 - $43,549	-641 Reduced 0.05%	1,357,594 $88.9 Million
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $7.2 Million - $8.36 Million	-122,978 Reduced 8.3%	1,358,235 $88.9 Million
Q1 2020 May 14, 2020	SELL	$49.46 - $64.78 $2.08 Million - $2.73 Million	-42,127 Reduced 2.77%	1,481,213 $89.2 Million
Q4 2019 Feb 11, 2020	BUY	$49.86 - $58.26 $1.02 Million - $1.2 Million	20,541 Added 1.37%	1,523,340 $88.2 Million
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $21,725 - $24,417	-457 Reduced 0.03%	1,502,799 $77.7 Million
Q2 2019 Nov 21, 2019	SELL	$46.79 - $52.47 $80,478 - $90,248	-1,720 Reduced 0.11%	1,503,256 $76.7 Million
Q2 2019 Aug 16, 2019	BUY	$46.79 - $52.47 $176,257 - $197,654	3,767 Added 0.25%	1,504,976 $76.8 Million
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $485,667 - $551,351	-10,476 Reduced 0.69%	1,501,209 $78.5 Million
Q4 2018 Feb 07, 2019	SELL	$41.54 - $47.25 $227,722 - $259,024	-5,482 Reduced 0.36%	1,511,685 $69.6 Million
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $258,536 - $283,305	-5,529 Reduced 0.36%	1,517,167 $71.5 Million
Q2 2018 Aug 10, 2018	BUY	$44.29 - $50.42 $333,946 - $380,166	7,540 Added 0.5%	1,522,696 $70.2 Million
Q1 2018 May 07, 2018	SELL	$48.49 - $58.14 $308,444 - $369,828	-6,361 Reduced 0.42%	1,515,156 $74.6 Million
Q4 2017 Feb 12, 2018	SELL	$47.53 - $53.73 $219,921 - $248,608	-4,627 Reduced 0.3%	1,521,517 $81.7 Million
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $62.8 Million - $75.1 Million	1,526,144	1,526,144 $73.5 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Novo Nordisk A S Transaction History